iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.200
-0.010 (-0.83%)
Oct 27, 2025, 9:57 AM EDT - Market open

iBio, Inc. Revenue

In the fiscal year ending June 30, 2025, iBio, Inc. had annual revenue of $400.00K with 77.78% growth. iBio, Inc. had revenue of $200.00K in the quarter ending June 30, 2025, with 14.29% growth.

Revenue (ttm)
$400.00K
Revenue Growth
+77.78%
P/S Ratio
31.76
Revenue / Employee
$20,000
Employees
20
Market Cap
24.31M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2025400.00K175.00K77.78%
Jun 30, 2024225.00K--
Jun 30, 2023---
Jun 30, 20221.88M-487.00K-20.54%
Jun 30, 20212.37M733.00K44.75%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings